Next-Generation CAR T-Cell Therapy for GBM: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 March 2024

  • curprev 10:0710:07, 30 March 2024‎ Lazy talk contribs‎ 2,479 bytes +154‎ No edit summary
  • curprev 10:0410:04, 30 March 2024‎ Lazy talk contribs‎ 2,325 bytes +2,325‎ Created page with "{{TreatmentInfo |drug_name=Next-Generation CAR T-Cell Therapy for GBM |FDA_approval=In trial phase for GBM; FDA-approved for other cancers |used_for=Recurrent Glioblastoma Multiforme (GBM) |clinical_trial_phase=Phase 1 (INCIPIENT trial among others) |common_side_effects=Fevers, altered mental status shortly after infusion, significant but manageable neurotoxicity |OS_without=Median survival for recurrent GBM typically less than one year |OS_with=Not fully established; dr..." Tag: Visual edit: Switched
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Next-Generation_CAR_T-Cell_Therapy_for_GBM"